Leading UK Pharmacies trust Deltera
A core oral treatment for weight management. This PGD enables the supply of Orlistat (Xenical), with Deltera’s logic managing the ongoing review process and monitoring for weight loss efficacy.
A Fully Digital Clinical Platform
Integrated Bookings and Payments
Secure & Connected Patient Records
Ditch the paperwork with secure digital records. Deltera automatically shares treatment summaries with the patient’s and sends the required notification to their GP instantly.
Training and Eligibility Requirements
To ensure clinical safety and regulatory compliance, all practitioners using this PGD must meet the following professional standards:
- Professional Registration: Must be a registered healthcare professional (e.g., Pharmacist) with a valid GPhC or PSNI registration and personal professional indemnity insurance.
- Clinical Competency: Practitioners must be self-certified as competent in the specific clinical area covered by this PGD and stay up to date with relevant national guidelines (e.g., The Green Book or NICE clinical summaries).
- Mandatory Training: Current certification in Basic Life Support (BLS) and the management of anaphylaxis is required for all injectable services.
- PGD Authorisation: The practitioner must have read and signed the PGD document within the Deltera Clinical Dashboard, with the authorisation counter-signed by the designated organisational lead or Superintendent.
- Premises Standards: Services must be conducted in a private consultation room that meets national standards for patient confidentiality and clinical safety.
Speak to the clinicians behind the platform
We understand the complexities of PGDs and clinical governance in the UK. Schedule a meeting with our team to see how we can help you navigate the changing landscape of community pharmacy.
Access related PGDs
FAQs
It is for those with a BMI of 30+ or 28+ with risk factors. Deltera’s pre-screen checks for specific contraindications like chronic malabsorption syndrome.
Regular reviews are required to monitor weight loss progress. Deltera helps you schedule these reviews and record the patient's weight at each consultation.
Yes. Clinical advice regarding the "low-fat diet" required for Orlistat is available in the patient portal, helping to reduce side effects and improve outcomes.
If the patient has not lost 5% of their body weight after 12 weeks, the Deltera system highlights this during the review, allowing the pharmacist to make a clinical decision.
Still have questions?
Our team are here to support you.
Discover Deltera Practice Management
Deltera Practice Management digitalises your private pharmacy services, providing the complete pharmacy software package to offer a full range of Patient Group Directions (PGDs). Gain the oversight and efficiency you need to thrive.
